Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
5Customers
3Debt Items
1Related Chains
Source-Backed Evidence Depth
PURE Bioscience, Inc. (PURE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
3Distinct source URLs
6High confidence
0.788Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
PURE Bioscience, Inc. Suppliers
Ticker
Name
Confidence
Evidence
VENDOR
VENDOR
90%
For the fiscal year ended July 31, 2024, one vendor accounted for 19 % of the Company's purchases.
Reciprocal relationship from VFF graph: Reciprocal relationship from PURE graph: Reciprocal relationship from VFF graph: se, after the date on which the statements are made or to reflect the occurren…
PURE Bioscience, Inc. Customers
Ticker
Name
Confidence
Evidence
CUSTOMER
CUSTOMER
90%
For the year ended July 31, 2024, one individual customer accounted for 20 % of the Company's net product sales.
INDIVIDUAL-CUSTOMER
INDIVIDUAL-CUSTOMER
90%
For the three months ended October 31, 2024, two individual customers accounted for 30 % and 10 % of the Company’s net product sales.
DELAWARE-GENERAL-CORPORATION
DELAWARE-GENERAL-CORPORATION
62%
od manufacturing practices” in order to ensure product quality, safety and effectiveness. Failure by us or our partners to comply with current or future government regulations and quality assurance g…
INTERCON-CHEMICAL-COMPANY
INTERCON-CHEMICAL-COMPANY
62%
y. Property, plant, and equipment consist of the following: Schedule of Property Plant and Equipment 2025 2024 July 31, 2025 2024 Computers and equipment $ 1,615,000 $ 1,615,000 Less accumulated depr…
ST-LOUIS-BASED-INTERCON-CHEMICAL-COMPANY
ST-LOUIS-BASED-INTERCON-CHEMICAL-COMPANY
62%
and partners, may not be successful in doing so, which would have a materially adverse effect on our business, financial condition and results of operations. 16 We have limited sales, marketing and p…
PURE Bioscience, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
PURE-DEBT-11956
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-07-31.
PURE-DEBT-11955
Warrants outstanding: 342116
90%
xbrl warrant detail from xbrl 2019-07-31.
PURE-DEBT
Debt stack $6.1M
90%
Market cache reports total debt of $6.1M.
PURE Bioscience, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for PURE Bioscience, Inc..
PURE Bioscience, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for PURE Bioscience, Inc..
PURE Bioscience, Inc. Extended Supply Chain Network
